Regulatory impact statement
Publication Date:
28 April 2016
This regulatory impact statement provides an analysis of options to change the regulation of therapeutic products. These include medicines, medical devices, and cell and tissue therapies and combinations thereof. The purpose of change is to advance coverage, safety, quality and access objectives.